Ruboxistaurin

Generic Name: Ruboxistaurin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₂₈N_₄O_₃

CAS Number: 169939-94-0

Unique Ingredient Identifier: 721809WQCP

Background: Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Edridge Green Lecture 2022—demystifying clinical trials and regulatory approvals in drug

References discuss treatments for age-related macular degeneration, diabetic macular edema, and inherited retinal dystrophies, including ranibizumab, aflibercept, and gene therapies like voretigene neparvovec.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy